Adaptive Biotechnologies Corpis A Biotechnology Company Based In Seattlewashingtonthe Company Focuses On Leveraging The Immune System To Create Innovative Diagnostic And Therapeutic Toolstheir Work Involves Decoding Immune Capabilities To Enhance Disease Diagnosis And Treatment Across Various Medical Fields The Company Offers An Immune Sequencing Platform That Supports Research In Oncology And Immune Mediated Diseasestheir Key Products Include Immunoseqwhich Is Used For Immune Profilingt Detect For T Cell Receptor Screeningand Clonoseq For Monitoring Minimal Residual Disease In Cancer Patientsadaptive Biotechnologies Is Also Involved In Vaccine Development Through T Cell Receptor Screening Their Products And Services Are Utilized By Healthcare Providers And Research Institutions In The U S Contributing To Improved Patient Care In Multiple Medical Areasthe Company Aims To Advance Immune Driven Medicine By Translating The Genetic Language Of The Adaptive Immune System Into Practical Clinical Applications
